anti-PD-1 antibodies
Showing 9976 - 10000 of >10,000
Solid Tumor, Non Small Cell Lung Cancer, Melanoma Trial in Lafayette, Boston, Nashville (AB248, Pembrolizumab)
Recruiting
- Solid Tumor
- +4 more
- AB248
- Pembrolizumab
-
Lafayette, Indiana
- +2 more
Jan 25, 2023
mRNA and miRNA Airway Inflammatory Markers
Completed
- COPD
- COPD Exacerbation
-
Groningen, NetherlandsUniversity Medical Center; Department of Pulmonary Diseases
Jul 8, 2021
Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis Trial in Madrid (Anti-TNF: Infliximab (Infusion), Anti-TNF
Active, not recruiting
- Crohn's Disease
- +2 more
- Anti-TNF: Infliximab (Infusion)
- +2 more
-
Madrid, SpainHospital Universitario de La Princesa
Mar 15, 2022
Acute Lymphoblastic Leukemia, in Relapse Trial in Belgium, France (GRASPA, L-asparaginase)
Completed
- Acute Lymphoblastic Leukemia, in Relapse
-
Bruxelles, Belgium
- +27 more
Feb 1, 2022
Hemostasis, Blood Biomarkers Trial in Manhasset (Volta System)
Not yet recruiting
- Hemostasis
- Blood Biomarkers
- Volta System
-
Manhasset, New YorkThe Feinstein Institutes for Medical Research
Aug 2, 2023
Myocardial Infarction Trial in Bern, Geneve (Alcohol consumption)
Recruiting
- Myocardial Infarction
- Alcohol consumption
-
Bern, Switzerland
- +1 more
Jun 16, 2023
Parkinson Disease Trial in Toronto (Physiotherapy)
Recruiting
- Parkinson Disease
- Physiotherapy
-
Toronto, Ontario, CanadaMovement Disorders Centre - Toronto Western Hospital
Jul 8, 2021
Advanced Solid Tumor Trial in Hangzhou (KN052)
Recruiting
- Advanced Solid Tumor
- KN052
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Jun 16, 2022
Opportunistic Autoimmune Diseases Trial in Strasbourg (Biological collection)
Recruiting
- Opportunistic Autoimmune Diseases
- Biological collection
-
Strasbourg, Alsace, FranceHopitaux universitaires de strasbourg
Aug 17, 2022
Insomnia Trial in Shanghai (Food, HEC83518, )
Recruiting
- Insomnia
- Food
- +2 more
-
Shanghai, Shanghai, ChinaThe Shanghai Xuhui Central Hospital
May 6, 2021
Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +10 more
- Bortezomib
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2022
MIND/COVID-19: Mental Health Impact and NeeDs Associated With
Active, not recruiting
- Covid19
- +2 more
-
Alcalá De Henares, Spain
- +17 more
Mar 16, 2022
Adipose Stromal Cells Due to Hemarthrosis After Knee Injury
Recruiting
- Post-Traumatic Osteoarthritis of Knee
- +2 more
- knee arthrocentesis
- +4 more
-
Nijmegen, Gelderland, NetherlandsRadboud umc
Jan 17, 2023
Crohn's Disease Trial in Stockholm (AZD7798, [11C]AZ14132516)
Not yet recruiting
- Crohn's Disease
-
Stockholm, SwedenResearch Site
Sep 22, 2023
Atopic Dermatitis Trial in Nice (Blood sample)
Not yet recruiting
- Atopic Dermatitis
- Blood sample
-
Nice, FranceNice University Hospital
May 11, 2023
Systemic Juvenile Idiopathic Arthritis, Periodic Fever Syndrome Trial in Shanghai (SSGJ-613, Placebo)
Recruiting
- Systemic Juvenile Idiopathic Arthritis
- Periodic Fever Syndrome
- SSGJ-613
- Placebo
-
Shanghai, Shanghai, ChinaShanghai Xuhui District Central Hospital
Aug 27, 2021
Sepsis Trial in United Kingdom (Prevenar 13, Sodium Chloride 0.9%)
Active, not recruiting
- Sepsis
- Prevenar 13
- Sodium Chloride 0.9%
-
Belfast, United Kingdom
- +11 more
Dec 12, 2022
HER2-positive or Mutated Advanced Colorectal Cancer Trial (Tislelizumab)
Not yet recruiting
- HER2-positive or Mutated Advanced Colorectal Cancer
- (no location specified)
May 16, 2022
Tennis Elbow Trial in Bologna (Injection of autologous leukocyte rich platelet rich plasma (LR-PRP), Injection of autologous
Recruiting
- Tennis Elbow
- Injection of autologous leukocyte rich platelet rich plasma (LR-PRP)
- +2 more
-
Bologna, ItalyIstituto Ortopedico Rizzoli
Sep 15, 2023